Varga, Gergely <br/><br/>
Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program.  [electronic resource] 

 -  Pathology oncology research : POR  Oct 2019 
 - 1615-1620 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-2807 
<br/><br/><label>Standard No.: </label>10.1007/s12253-019-00607-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Boron Compounds--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Glycine--administration & dosage<br/>Humans<br/>Hungary<br/>Lenalidomide--administration & dosage<br/>Male<br/>Multiple Myeloma--drug therapy<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prognosis<br/>Retrospective Studies<br/>Safety<br/>Salvage Therapy<br/>Survival Rate